La sindrome da incompetenza cavernosa e l'ipogonadismo secondario dell'andromiosi: Condizioni correlate o concomitanza occasionale?: Venous leakage syndrome and “andromiosis” hypogonadism: Are they correlated or are they an occasional coincidence?
Restricted accessResearch articleFirst published online April, 1998
La sindrome da incompetenza cavernosa e l'ipogonadismo secondario dell'andromiosi: Condizioni correlate o concomitanza occasionale?: Venous leakage syndrome and “andromiosis” hypogonadism: Are they correlated or are they an occasional coincidence?
The study of available case histories enables us to formulate some interesting hypotheses on the relationship between andropause hypogonadism and cavernous incompetence erectile deficit. Such conditions may well be connected to a similar degenerative or aging process which, provided both conditions are present, may be responsible for the worsening of the erectile deficit. Correction of the hormone deficit does not produce any recovery of spontaneous erectile activity but it significantly improves response to standard treatment for impotence.
MorroneG., NotoA., VignaA., TalaricoP.: Studio epidemiologico del deficit erettivo: esperienza U. di Andrologia Osp. di Cosenza. X Congr. Soc. It. Andrologia, 617–619, 1996.
2.
GovierF.E., McClureD., Kramer-LevienD.: Endocrine screening for sexual dysfunction using free testosterone determinations. J. Urol., 156: 405–408, 1996.
3.
GrayA., FeldmanH.A., McKinlayJ.B., LongcopeC.: Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J. Clin. Endocrinol. Metabol., 73: 1016–1025, 1991.
4.
MullerC.: Memento: gli esami di laboratorio. (Trad. ed. francese Maloine), 95, 1996.
5.
Puech-LeaoP., ReisJ., GlinaS., ReicheltA.: Leakage through the crural edge of corpus cavernosum. Diagnosis and treatment. Eur. Urol., 13: 163–165, 1987.
6.
MoralesA., JohnstonB., HeatonJ.P., LundieM.: Testosterone supplementation for hypogonadal impotence assessment of biochemical measures and therapeutic outcomes. J. Urol., 157: 849–854, 1997.
7.
KorenmanS., MorleyJ., MooradianD., DavisS., KaiserF., SilverA., VioscaS., GarzaD.: Secondary hypogonadism in older men: its relation to impotence. J. Clin. Endocrinol. Metabol., 71: 963–969, 1990.
8.
SeyamR., HuynH., BeginR., AbdelbakyT., LiebermanH., BrockG.: Androgen regulation of erection: effect on translation and transcription of nitric oxide synthase in rat penis and major pelvic ganglion. 24° Congr. SIU. Br. J. Urol., 80(S2): 377, 1997.
9.
HoritaH., SatoY., KurohataT., AdachiH., TsukamotoT.: Effect of testosterone replacement on nitric oxide in the rat brain. Congr. AUA. J. Urol., 157: 1400, 1997.
10.
SattarA., Moreira de GoesP., NoelJ., WespesE., SchulmannC.: Objective analysis of intracavernous structures in potent and impotent patients. XI Congr. EAU, abs. 116, 1994.
11.
PassavantiG., RossiA., RondanelliE., CariniU., PizzutiV., BragagliaA., PaoliniR.: La diagnosi di sindrome da fuga venosa: il ruolo della biopsia dei corpi cavernosi e della PO2 del sangue cavernoso dopo FCM. X Congr. SIA, 171–175, 1996.
12.
GoorenL.J.: The age-related decline of androgen levels in men: clinically significant? Br. J. Urol., 78: 763–768, 1996.
13.
GuayA., BansalS., HeatleyG.: Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate. J. Clin. Endocrinol. Metabol., 80: 3546–3552, 1995.
